Cytosorbents Cor (CTSO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 09-2015 | 06-2015 | 03-2015 | 12-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -9,477 | -6,130 | -3,283 | -4,717 | -9,322 |
| Depreciation Amortization | 113 | 78 | 44 | 21 | 264 |
| Accounts receivable | 132 | 237 | 284 | 104 | -412 |
| Other Working Capital | -452 | -425 | -163 | 215 | -608 |
| Other Operating Activity | 637 | -583 | -1,442 | 2,416 | 3,797 |
| Operating Cash Flow | $-9,048 | $-6,822 | $-4,559 | $-1,961 | $-6,281 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -248 | 2 | -1,244 | -995 | -1,945 |
| PPE Investments | -404 | -296 | -193 | -104 | -153 |
| Purchase Sale Intangibles | -240 | -128 | -45 | -36 | -214 |
| Other Investing Activity | -240 | -128 | -45 | -36 | -214 |
| Investing Cash Flow | $-891 | $-423 | $-1,481 | $-1,135 | $-2,312 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 2,116 | 1,636 | 1,068 | 603 | 266 |
| Other Financing Activity | 9,524 | 9,409 | 9,409 | 9,409 | 9,751 |
| Financing Cash Flow | $11,640 | $11,044 | $10,476 | $10,012 | $10,017 |
| Exchange Rate Effect | 10 | -19 | -24 | -103 | -2 |
| Beginning Cash Position | 3,605 | 3,605 | 3,605 | 3,605 | 2,183 |
| End Cash Position | 5,317 | 7,386 | 8,017 | 10,419 | 3,605 |
| Net Cash Flow | $1,712 | $3,780 | $4,412 | $6,813 | $1,422 |
| Free Cash Flow | |||||
| Operating Cash Flow | -9,048 | -6,822 | -4,559 | -1,961 | -6,281 |
| Capital Expenditure | -404 | -296 | -193 | -104 | -153 |
| Free Cash Flow | -9,451 | -7,119 | -4,752 | -2,065 | -6,434 |